

IntractMD is designed to move medication review from isolated interaction checking toward a broader view of medication risk, workflow and follow-up.
Prescription medications, OTC products, supplements and foods can be screened together. Results are presented in plain language.
Publicly available at intractmd.com
Given a medication profile, identify supplements and foods that may create interaction concerns. Designed for health plans and pharmacy organizations.
A structured six-step workflow combining interaction analysis, 28-factor polypharmacy risk stratification and confidence-tiered patient outreach in English or Spanish.
Uses published deprescribing criteria — AGS Beers Criteria®, STOPP/START v3 and CMS Star Ratings measures — and hypothetical medication-removal scenarios to help clinicians identify where review may begin.
IntractMD combines authoritative medication data from FDA drug labeling, NLM RxNorm, and MedlinePlus with a comprehensive interaction knowledge base to deliver rapid, patient-specific medication risk analysis.
AI-assisted analysis helps synthesize medication-risk information and identify potential risk patterns. IntractMD distinguishes established findings, computed signals and predictive findings rather than presenting an AI inference as a confirmed clinical fact. Structured clinical communication can be generated in English or Spanish, with outputs remaining subject to clinical review.
Evaluate the platform on Resolve Medical infrastructure. No software installation or EHR integration required to begin.
Expose medication-intelligence capabilities inside an existing care-management, pharmacy or patient platform.
License selected capabilities as a medication-intelligence layer for strategic technology partners.
We can scope a focused 60-day evaluation around a specific population, medication-review workflow or partner use case.